LexDanaLexDanabeta
Inventor

William F. Vernier

Inventor
St. Louis, MO, US

Overview

42→
Patents
2002–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 42 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds25%
C07BGeneral methods of organic chemistry20%
C07CAcyclic or carbocyclic compounds20%
B01DSeparation14%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations10%
A61KPreparations for medical, dental or toiletry purposes8%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1%
Y02ATechnologies for adaptation to climate change1%
PatentTitleYear
10,981,916Substituted pyrazolopyrimidinone compounds as PDE2 inhibitors202110,501,465Substituted [1,2,4]triazolo[1,5-A]pyrimidin-7-yl compounds as PDE2 inhibitors20199,932,345Substituted [1,2,4]triazolo[1,5-A]pyrimidin-7-yl compounds as PDE2 inhibitors20187,700,658'(R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity'20107,253,211'(R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity'20077,122,536'(R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity'20067,119,203'Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors'20066,909,001'Method of making tricyclic aminocyanopyridine compounds'20056,803,388'(R)-Chiral halogenated substituted n,n-bis-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,765,023'Use of substituted N, N-disubstituted reverse aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,750,228'Aromatic sulfone hydroxamic acid metalloprotease inhibitor'20046,750,233'Aromatic sulfone hydroxamic acid metalloprotease inhibitor'20046,723,752'(R)-chiral halogenated substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,723,753'Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,710,089'Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,699,898'Substituted N,N-disubstituted non-fused heterocyclo amino compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,696,472'Substituted N-phenoxy-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,696,435'Substituted N,N-disubstituted fused-heterocyclo amino compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,683,113'(R)-chiral halogenated substituted N,N-Bis-benzyl aminioalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,683,093'Aromatic sulfone hydroxamic acids and their use as protease inhibitors'20046,683,099'Substituted N,N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,677,341'(R)-Chiral halogenated substituted heteroaryl benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,677,382'Substituted N,N-bis-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,677,375'Substituted N,N-bis-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,677,379'Substituted N,N-disubstituted diamino compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,677,380'Substituted N, N-disubstituted mercapto amino compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,677,353'Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,586,433'Substituted N-heteroaryl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20036,583,183'Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20036,544,974'(R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesteryl ester transfer protein activity'20036,521,607'(R)-chiral halogenated substituted N-phenoxy N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20036,479,552'Use of substituted N, N-disubstituted diamino compounds for inhibiting cholesteryl ester transfer protein activity'20026,476,075'Use of substituted N, N-bis-benzyl aminoalcohol compounds inhibiting cholesteryl ester transfer protein activity'20026,476,057'Use of substituted N, N-disubstituted cycloalkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity'20026,462,092'Use of substituted N, N-disubstituted reverse aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity'20026,458,852'Use of substituted N, N-bis-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity'20026,458,803'Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity'20026,458,849'use of substituted N,N-disubstituted mercapto amino compounds for inhibiting cholesteryl ester transfer protein activity'20026,455,519'Use of substituted N, N-disubstituted fused-heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity'20026,451,830'Use of substituted N,N-disubstituted non-fused heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity'20026,451,823'Use of substituted N-phenoxy-N-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity'20026,448,295'Use of substituted N-fused-phenyl-N-benzyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity'2002

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2002–2003Patents assigned to SEARLE & CO (12)· patent assignee history
2002–2010Based in St. Louis, MO, US· patent location history
2003–2006Patents assigned to PHARMACIA CORP (21)· patent assignee history
2004–2010Patents assigned to PFIZER (5)· patent assignee history
2005Based in Oceanside, CA, US· patent location history
2018–2019Patents assigned to DART NEUROSCIENCE CAYMAN LTD (2)· patent assignee history
2018–2019Based in Vista, CA, US· patent location history
2021Patents assigned to DART NEUROSCIENCE LLC (1)· patent assignee history
2021Based in San Diego, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
PHARMACIA CORP212003–2006
SEARLE & CO122002–2003
PFIZER52004–2010
DART NEUROSCIENCE CAYMAN LTD22018–2019
DART NEUROSCIENCE LLC12021
Locations
LocationPatentsSpan
St. Louis, MO, US382002–2010
Vista, California, US22018–2019
San Diego, California, US12021
Oceanside, California, US12005